Cincinnati Children's Hospital Medical Center: NEJM Study Shows Drug Saves Lives of Kids Fighting Deadly Immune Disease
May 07, 2020
May 07, 2020
CINCINNATI, Ohio, May 7 -- The Cincinnati Children's Hospital Medical Center issued the following news release:
After 20 years of trying, modern medicine remains unable to lower the roughly 40 percent mortality rate for the severe childhood immune disease called HLH (hemophagocytic lymphohistiocytosis), which damages vital organs and tissues.
Now, researchers report in the New England Journal of Medicine treating patients with a new drug that saved kid's lives . . .
After 20 years of trying, modern medicine remains unable to lower the roughly 40 percent mortality rate for the severe childhood immune disease called HLH (hemophagocytic lymphohistiocytosis), which damages vital organs and tissues.
Now, researchers report in the New England Journal of Medicine treating patients with a new drug that saved kid's lives . . .